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Abstract: 
ATP binding cassette transporters are a large family of integral membrane transport 
proteins which have vital functions in prokaryotic and eukaryotic organisms. The genome 
of Candida albicans, the most important opportunistic fungal pathogen in humans, 
harbors more than ten ABC transporter genes belonging to four ABC transporter 
subfamilies. In previous studies, we have characterized the Mlt1 ABC transporter, a 
member of the multidrug resistance-associated protein (MRP) subfamily of ABC 
transporters. Ycf1 (yeast cadmium factor 1), another member of this subfamily, initially 
was found in Saccharomyces cerevisiae sharing 42.6% identity with human MRP1. In 
this study we have begun to characterize the C. albicans orthologue of Ycf1 using gene 
disruption mutants and wild-type controls in cadmium and mercuric chloride 
susceptibility testing. Green fluorescent protein (GFP) fusion proteins were utilized to 
determine the cellular localization of the ABC transporter in C. albicans yeast and hyphal 
forms. Additionally, we use quantitative reverse transcriptase PCR to investigate ABC 
transporter gene expression. Our results indicate that the Ycf1 orthologue in C. albicans 
localizes to the vacuolar membrane of the fungi and appears to be involved in 
detoxification of cadmium and mercury, similar to the S. cerevisiae transporter. The gene 
expressions analyses revealed upregulation of the YCF1 mRNA during mercury exposure, 
further confirming the transporter’s role in mercury detoxification. Future studies will 
focus on the role of Ycf1 in vacuolar function and inheritance of C. albicans as well as its 
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The eukaryotic microorganisms belonging to the Kingdom Fungi include molds and 
yeasts. Fungal saprobes are crucial for the decomposition of organic material, nutritional 
exchange and biogeochemical cycling in the environment. Humans have been using 
many species of fungi as food, for food production, or in recent decades in 
biotechnological applications such as production of enzymes, vitamins, and many other 
valuable chemicals. In scientific research, the yeast Saccharomyces cerevisiae has been 
an essential eukaryotic model organisms to study fundamental cell biological, genetic, 
and molecular biological processes. However, some fungi also have gained notoriety as 
mainly opportunistic pathogens in the increasing population of immunocompromised 
patients. 
In the past, scientists considered fungi as closely related to plants; however, cell 
biological and molecular evidences have shown significant differences between these two 
groups of organisms. For example, chitin in the fungal cell wall is substituted by cellulose 
in plant cell walls. Additionally, as the principal decomposers in ecological systems, 
fungi do not undergo photosynthesis, but as chemoheterotrophs they gain energy through 
the break-down of organic material from the environment. While fungi are widespread in 
ecosystems, most of them are indiscernible due to their microscopic size, with the
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exception of the fruiting bodies (mushrooms) of macroscopic fungi. 
Fungi can have symbiotic, commensal, or parasitic relationships with animals, plants or 
other microorganisms. Some of species produce mycotoxins which can be highly toxic to 
human and animals. The members of the fungal kingdom can vary substantially in 
ecologies, life cycles, and morphologies, each contributing to the vast diversity of this 
organismal group. To date, our knowledge of fungi still is limited, only 5% of species 
have been identified and classified from an estimated 2.5 million to 4 million species in 
the world. Through the development of molecular techniques in recent decades, DNA 
sequencing has replaced the classical approach towards fungal classification by 
morphological characteristics. Some of the well-known species such as S. cerevisiae and 
Candida albicans were the first fungal species with available whole genome sequences 
[1].  
Candida albicans is one of the most-studied fungal pathogens. It is a strictly diploid 
opportunistic pathogen that causes a wide range of infections in immunocompromised 
hosts. Most incidences of candidiasis are endogenous infections because the fungi are 
part of the normal human microbiota found in the mouth, gut, vagina, and skin in many 
individuals [2]. Candida species are mesophilic and thus able to grow at human body 
temperature, an important prerequisite for a pathogen – many other fungi are not 
pathogenic for warm-blooded animals because of growth temperature restrictions. 
As a commensal in health individuals, C. albicans presents predominantly in its budding 
yeast form, usually in low numbers as it is only a minor component of the human 
microbiota. However, when normal physical, microbiological, and immune defenses are 
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interrupted or repressed because of trauma, broad-spectrum antibiotic use or 
immunosuppression, C. albicans and related non-albicans Candida species (e.g., C. 
tropicalis, C. glabrata, C. krusei) can become pathogenic and break through tissue 
barriers to cause superficial to deep-seated infections. The symptoms of candidiasis 
largely depend on the infecting Candida species, the location and severity of infection, 
and the host’s immune status. In the mouth, candidiasis may present as oral thrush or 
pseudomembranous candidiasis. Vulvovaginal candidiasis may cause itching and burning, 
in some patients with certain immune defects with an increased rate of recurrence. Severe 
infections with invasion of blood vessels and hematogenous spread are seen especially in 
neutropenic patients, for example, those receiving chemotherapy for treatment of 
leukemia [3]. Most forms of severe candidiasis are associated with invasion and 
overgrowth in target organs which requires adaptation of the pathogen to different 
microenvironmental conditions. The ability to grow in different morphologies, as 
budding yeast or in filamentous forms (hyphae, pseudohyphae) helps C. albicans to adapt 
to different conditions in the hosts [4]. While a recent study claims that the yeast to 
hyphae transition is not always necessary for virulence of C. albicans, the hyphal form of 
C. albicans could still support infection, for example, by promoting invasion and 
hematogenous dissemination of the fungi [5]. In addition to morphological conversions, 
other adaptive survival mechanisms are involved in the pathogenesis of the different 
forms of candidiasis. Furthermore, development of antifungal drug resistance can 
exacerbate these diseases by rendering them difficult to treat successfully. 
The aim of this study was to investigate the role of specific transport proteins in the 
detoxification of harmful substances and homeostasis of cellular functions. Among the 
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many transport proteins encoded in the Candida genome are energy-driven ATP-binding 
cassette (ABC) transporters. A specific subset of these transporters is not localized in the 
plasma membrane, but appears to perform transport functions in a specific organelle 
related to lysosomes in higher organisms, the fungal vacuole. Some vacuolar ABC 
transporters have been characterized in greater detail in the non-pathogenic S. cerevisiae 
and a smaller number in the opportunistic pathogen C. albicans. The latter, for example, 
harbors the MRP-related transporter Mlt1 which was discovered previously by Theiss et 
al. [6] and has been studied in greater detail [6, 7]. Here, we focus on the closely related 
transporter CaYcf1 whose putative orthologue has been characterized in S. cerevisiae as a 
vacuolar transporter involved in detoxification of cadmium; however, little is known 
about the functions of this transporter in the opportunistic pathogen C. albicans. This 
study is an initial in vitro functional characterization of this transporter which could be an 






REVIEW OF LITERATURE 
Candida albicans 
C. albicans is a budding yeast with round or oval-shaped cells with diameters from 3 to 
6 μm. Even though it is a diploid organism, no evidence of meiosis and a natural haploid 
phase has been found [8-10]. While budding is the mode of reproduction in the yeast 
form, C. albicans filamentous morphologies encompass the formation of pseudohyphae 
and true hyphae.  
C. albicans is the most prevailing of the opportunistic Candida species – it causes the 
majority of clinical representations of candidiasis [11]. Whether or not disease occurs 
after invading the human body depends on the immune status of the human host, the 
number of invasive cells and expression of certain virulence factors. In the healthy, non-
immunocompromised host, Candida is a commensal present in low numbers of 
predominantly yeast cells. However, in immunodeficient populations, C. albicans can 
transform its morphology from yeast to hyphae and invade mucosal tissue [12]. This 
pleomorphic ability of C. albicans, i.e., growing in the yeast, pseudohyphal, or hyphal 
form, is an important factor in the fungus’ virulence. During the morphological switching 
from yeast to hyphae, additional virulence factors for adhesion and invasion are 
differentially expressed. Earlier studies have shown that different temperature and the
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presence of carbon dioxide may affect the morphological forms of C. albicans [13]. The 
purpose for this morphological transitions appears to be adaptation to changing 
(micro)environmental conditions. Previous research showed that the virulence of C. 
albicans mutants unable to form hyphae (because of specific mutations in regulatory 
factors), is largely reduced [14]. Researchers argued that true hyphae are not essential for 
tissue invasion, because other species such as C. glabrata and C. parapsilosis, which are 
also relatively common causes of disseminated candidiasis, do not produce true hyphae 
[15]. C. glabrata, which only presents in yeast form, does have the ability to cause 
oropharyngeal candidiasis by binding to co-infecting C. albicans hyphae [16]. Generally, 
there appears to be no doubt that the ability to form hyphae increases virulence. For 
example, a recent study on C. albicans and C. dubliniensis in mouse systemic infection 
models showed that both species can produce hyphae and their virulence is potentiated by 
hyphae formation [17]. 
One way hyphae increase virulence is by induction of the expression of many additional 
proteins such as the agglutinin-like sequence protein 3 (Als3), which is important for 
adhesion, the secreted aspartic proteases family (e.g., Sap4, Sap5, Sap6, Sap9, Sap10), 
and the hypha-associated GPI-linked protein (Hwp1), another important adhesin [18]. 
Additionally, Hwp1 and Als3 as complementary adhesins could also aid in biofilm 
formation [19]. Besides its ability to improve adhesion, Als3 also plays an important role 
in invasion [20].  
Overall, the current thinking is that hyphae break the normal cell defense boundaries and 
penetrate to deeper cell layers which causes damage in underlying tissues. According to 
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recent studies, the hyphal form will induce endocytosis or active penetration to invade 
host cells [21]. 
Apart from adhesion and invasion, another significant virulence factor of C. albicans is 
the ability to generate biofilms. The formation of biofilms is a continuous process, 
beginning with the attachment of yeast cells to their substrate, followed by formation of 
hyphae and extracellular material and leading to redistribution of cells from those mature 
glutinous complexes [22]. Furthermore, within biofilms, cells are more resistant to 
antibiotics and host immune responses [23].  
Innate immune responses towards C. albicans are mediated by pattern recognition 
receptors (PRRs) which recognize the pathogen-associated molecular patterns (PAMPs) 
exposed by C. albicans cell walls. This process could help the immune system to 
differentiate harmful pathogens from normal microbiota [24]. Once C. albicans leaves 
the bloodstream, neutrophils and macrophages will stand guard to kill the intruder. 
Macrophages will simply try to engulf this pathogen and destroy the fungi intracellularly. 
However, neutrophils are the most effective and essential defending cells for protecting 
the human body from C. albicans infection with the ability to prevent hyphae formation 
[25]. Once a pathogen has been recognized, neutrophils will release reactive oxygen 
species (ROS), which induce oxidative stress to suppress fungal cell growth, and form 
neutrophil extracellular traps (NETs) [26]. NETs appear to be able to entrap and kill 
filamentous forms of C. albicans which cannot be successfully internalized by phagocytic 




When C. albicans becomes a pathogen, dendritic cells as antigen presenting cells (APC) 
play an important role both in innate and adaptive immunity. By recognizing pathogen-
associated molecular patterns on the C. albicans cell wall, dendritic cells could trigger the 
adaptive T cell immune protection against C. albicans infection [27]. The dynamic and 
complicated signaling to initiate adaptive immunity has not been fully understood. 
In previous studies, C. albicans has been proven to have frequent karyotypic variation in 
response to different environmental stressors. Such variations in genome structure could 
pose a problem for many other fungi which regularly process through a post-meiotic 
haploid phase [28]. The diploid C. albicans, however, has a large capacity to tolerate 
karyotypic variation due to its highly heterogeneous and plastic genome [29]. In other 
words, C .albicans can adjust its genome in response to external triggers and quickly 
adapt to a changing environments. 
 
Candidiasis 
Candidiasis is the most common fungal disease. It can present as an acute, subacute, or 
chronic infection. Besides superficial and cutaneous mycoses, Candida spp. can cause 
deep-seated, hematogenously disseminated and systemic infections that are associated 
with high morbidity and mortality [30]. The clinical symptoms are commensurate with 
the area infected. In recent years, with the increased use of broad-spectrum antibiotics, 
hormones, and immunosuppressive agents, the incidence of candidiasis has increased 
while incidences of HIV-related opportunistic Candida infections have decreased in 
countries with available highly active antiretroviral therapy (HAART) [31]. 
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Depending on the site of infection, candidiasis could be classified into different 
categories. For example, cutaneous candidiasis is more common in people with chronic 
exposure to wet environments who have interdigital erosions on the hands. A rash with 
itchy or painful feeling is the most common symptom, and peripheral areas are often 
scattered with red papules or pustules. Candida paronychia is common around infected 
nails [30-35]. 
Mucosal candidiasis refers to infections in genital areas or the mouth. Thrush is common 
in infants and young children. There is a clear white pseudomembrane at the oral mucous 
membranes, pharynx, tongue and gums with peripheral areas of redness. Genital 
candidiasis includes vulvovaginitis and balanoposthitis. Infections in males are rare, but 
vulvovaginal candidiasis is common in females of reproductive age. Vaginal secretions 
and grayish white patches on the vaginal wall with itching or burning are common 
symptoms of this infection [30, 31, 34-36]. 
Systemic Candida infections can affect all internal organs – relatively common are 
intestinal candidiasis and pulmonary candidiasis. These diseases are more common in 
clinically immunodeficient patients, especially in patients with long-term use of 
antibiotics or corticosteroids. Candidal enteritis is associated with abdominal discomfort, 
hypermotility, chronic diarrhea and anal itching. Candidal bronchitis is associated with 
cough and the presence of the pathogen in mucous phlegm. In addition, Candida can 




Candida rashes are skin allergies caused by contact to the microorganism and its 
metabolic products, the main damage is formation of aseptic blisters, mostly found on 
fingers with psoriasis, rose blisters, seborrheic dermatitis and urticaria. Candidal 
endophthalmitis is seen in immunocompromised, diabetic, and candidemic patients. 
Although candidal endophthalmitis is a rare disease among ophthalmic infectious 
diseases, it has shown a tendency to increase with the widespread use of 
immunosuppressant therapy, long-term antibiotic therapy, long-term indwelling catheters, 
and intravenous injections [30, 34, 35]. 
Direct microscopic examination of specimens is an effective method to diagnose some 
forms of candidiasis. Culture of clinical isolates on specialized agar plates (e.g. CHROM 
agar) is another possible diagnostic approach for various Candida species. Germ-tube 
tests and biochemical tests may be the alternatives, but molecular methods have become 
increasingly relevant in Candida diagnostics [34]. 
 
Fungal Vacuoles 
Vacuoles are ubiquitous structures in plant cells [37]. They are metabolic libraries and act 
as regulators of the intracellular environment. Generally speaking, vacuoles are round 
shaped organelles surrounded by a membrane with an internal aqueous solution 
containing salts, sugars, and pigments. As an enclosure surrounded by membrane, they 
could be employed for sequestration of toxic substances and waste products within the 
cell. Additionally, they also could aid in maintaining intracellular pH and provide storage 
capacity. The concentration of H+ can reach very high levels and the intravacuolar pH is 
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generally acidic. The main functions of vacuoles in plants are the regulation of the 
osmotic pressure of cells, maintenance of the balance of water in cells as well as 
accumulation and storage of nutrients and various metabolites. Substances that are stored 
and accumulated in vacuoles include sugars, proteins, phospholipids, tannins, organic 
acids, plant alkaloids, pigments, and salts. The specific conditions vary depending on the 
type of plant, the site of organ tissue, and the degree of maturity. There are large amounts 
of small spherical vacuoles in juvenile cells at the plant root and stem tips. During cell 
maturation, multiple small vacuoles fuse into a large vacuole. A similar fusion process is 
commonly seen in fungi, although fungal vacuoles are more dynamic and single large 
vacuoles can readily separate into smaller vacuoles due to changes of environment. 
Fungal vacuoles, if mature enough, are able to reduce the requirement for cell nutrition. 
During the life cycle of fungal cells, vacuoles change in size, shape and number to 
response to needs of metabolic demands and cell cycle timing [38]. Several vacuolar 
functions are mediated by ABC transporters in the organelle’s membrane.  
The fungal vacuole also is responsible for degradation of intracellular components, 
similar to the function of lysosomes in mammalian cells [39]. Moreover, yeast vacuoles 
appear to play a role in autophagy [40]. In general, fungal vacuoles are extremely 
dynamic and frequently expanding and changing their numbers and shape in response to 
environmental change. Increasing evidence shows that during the life cycles of fungal 
pathogens, vacuoles are involved in morphological changes such as germ tube formation 
in C. albicans [41].  
Another function for fungal vacuole is storage and sequestration of toxic compounds. 
Through specific transporters in the vacuolar membrane, lipids, amino acids, and 
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metabolic waste products can be pumped into vacuoles. Additionally, the ability to store 
glutathione-conjugation complexes is important for detoxification of toxic metals. While 
the exact mechanisms how these metals are detoxified with the help of vacuoles remain 
to be elucidated, specific ATP-binding cassette transporters appear to facilitate transport 
of these complexes across the vacuolar membrane. 
 
ATP-Binding Cassette Transporters 
The ATP-binding cassette (ABC) transporters are integral membrane proteins which have 
the capacity for directed, energy-driven transfer of chemicals and other components from 
one side of the membrane to the other via consumption of ATP.  
These ubiquitous proteins are highly diverse and essential for many metabolism 
processes. While most ABC transporters have two trans-membrane domains (TMDs) and 
two nucleotide binding domains (NBDs), their functional diversity is also reflected by 
structural diversity. 
Within the superfamily of ABC proteins, full-size ABC transporters share mutual 
topologies which comprise four domains, two TMDs with several transmembrane regions 
that help to establish the substrate translocation channel and two NBDs. 
A detailed classification of ABC proteins depends on the sequence similarities of their 
nucleotide binding domains. Generally, ABC proteins are classified into seven 
subfamilies: the ABCA, ABCB, ABCC, ABCD, ABCE, ABCF and ABCG subfamilies 
[42]. However, the ABCE and ABCF subfamilies do not have the ability to transport 
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substrates across membranes because of lacking actual trans-membrane spans, 
nevertheless the presence of NBDs warrants their inclusion in the ABC protein 
superfamily [43]. 
As mentioned above, the core structure of ABC transporters are two TMDs consisting of 
several trans-membrane spans and interspersed amino acid loops as well as two NBDs 
which are highly conserved in all ABC transporters [44].  
The NBDs belong to the subfamily of P-loop NTPases and have the function to hydrolyze 
ATP [45]. When binding and hydrolyzing ATP, NBDs will rearrange and cause 
conformational transformation of the TMDs [44]. The TMDs allow for substrate access 
to one or both sides of the membrane and are responsible for transport of the substrate via 
this transformation. 
The ABC subfamily C (ABCC) transporters such as the human multiple drug resistance-
associated protein 1 (Mrp1) or the yeast cadmium factor protein in S. cerevisiae (ScYcf1p) 
encompass a N-terminal extension with an additional TMD (TMD0) [46]. 
Besides the TMD and NBD core structures, there are additional regulatory domains in 
ABC transporters called accessory domains. The regulatory functions include increasing 
the affinity to and enhancing the binding of substrates [47]. Functions not directly related 
to transportation such as supporting chaperoning and signal transduction are also 
mediated by these accessory domains [47]. 
The structural diversity of ABC transporters highly implies different transportation 
mechanisms, but even in transporters with similar structures, the transported range of 
substrates may be quite different [48]. 
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Due to their wide range of locations, from intracellular organelle membranes, such as 
vacuolar or peroxisomal membranes, to the plasma membrane, ABC transporters provide 
a wide array of crucial functions. Additionally, ABC proteins also have important 
functions as ion channels, channel regulators and proteases [49]. Although each ABC 
transporter transports a limited range of substrates, the protein family has members 
capable of transporting ions, amino acids, nucleotides, polysaccharides, polypeptides, and 
even proteins. Some ABC transporters also catalyze the turnover of lipid bilayer 
phospholipids between the two layers (flippase activity), which is of great significance in 
homeostasis and functional maintenance of the membrane. ABC transporters are also 
involved in the resistance of pathogens to antimicrobial drugs such as clinically used 
antibacterial or antifungal drugs (see below for further details). In humans, the 
overexpression of multiple drug resistant (MDR1) and multiple drug resistant-like 
(MRP1) protein enhances resistance of tumor cells to chemotherapeutic drugs [50]. 
ABC transporters are also involved in essential transport functions for maintaining the 
blood-brain barrier to keep toxin and metabolic waste products from entering the CNS 
[51]. Inherited diseases like cystic fibrosis are caused by loss of function mutations in the 
CFTR ABC transporter [52]. Overall, better understanding of the cellular functions and 
mechanisms of transport by ABC transporters is important for cell biology, chemotherapy 
and prevention of human diseases. As eukaryotic microorganisms amenable to genetic 
manipulation, fungi such as S. cerevisiae and C. albicans have become ideal models for 
investigating the functional roles of ABC transporters. 
Research in C. albicans, with some exceptions in infection-related studies, has benefited 
considerably from research in the model microorganism S. cerevisiae. C. albicans 
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naturally shares some properties with S. cerevisiae, including most of the inventory of the 
ATP Binding Cassette (ABC) transporters in the vacuolar membrane. For example, 
putative orthologues of the S. cerevisiae ABCC transporters yeast cadmium factor 1 
(ScYcf1p) and bile pigment transporter 1 (ScBpt1) appear to be encoded in the 
C. albicans genome [53, 54].  
This study focused on the C. albicans orthologue of ScYcf1p due to its prolific functions 
in S. cerevisiae. Ycf1p is the best characterized member of the ABCC subfamily of ABC 
transporters in S. cerevisiae. 
 
Ycf1 Protein 
Similar to other full-size ABC transporters, ScYcf1p has two NBDs and two TMDs. 
Additionally, the protein harbors an extra N-terminal extension (NTE) with five trans-
membrane spans and an additional cytosolic loop (L0), typical features of full-length 
ABCC subfamily transporters[46]. It has been demonstrated that the short cytosolic loop 
is essential for substrate specificity, which means it may be involved in binding of 
glutathione-conjugate complexes, whereas the N-terminal extension is involved in 
vacuolar trafficking [55]. 
The yeast cadmium factor 1 protein in S. cerevisiae (ScYcf1p) was first found when the 
yeast was exposed to cadmium sulfate solution – overexpression of the gene conferred 
cadmium resistance [56-59]. Conversely, inactivation of the ScYCF1 gene rendered S. 
cerevisiae hypersusceptible to cadmium. Interestingly, while ScYcf1p was first believed 
to reside in the plasma membrane, it actually resides in the vacuolar membrane [57]. 
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Previous studies have proven that Ycf1p can pump cadmium into the vacuole via 
bis(glutathionato)cadmium complexes (Cd•GS2) and trapping of these complexes inside 
the vacuole clearly demonstrated the heavy metal detoxification capacity of ScYcf1p [56]. 
Another study also showed that ScYcf1p plays a role in mercury detoxification [60]. 
Similar to cadmium detoxification, glutathione-conjugated mercury will be firstly formed 
and then sequestered into the yeast vacuole by ScYcf1p [60]. This indicates not only 
cadmium, but other heavy metals undergo similar detoxification mechanisms mediated 
by ScYcf1p. 
Interestingly, ScYcf1p exhibits high amino acid similarity (63%) with the human 
multidrug resistance-associated protein 1 (Mrp1p) [57, 61]. Therefore, it is possible is 
that these proteins share similar functions. A comparative study revealed that 
heterologous expression of human MRP1p complemented the disruption of the ScYCF1 
gene by restoring the glutathione-conjugate transporter function in these yeast mutants 
[61]. This experiment suggested that ABCC transporters may share similar functions 
even across kingdom boundaries, making yeast a promising research model for 
investigation of these transporters.  
In addition to its major function in metal-glutathione-conjugate transport ScYcf1p also 
appears to be involved in the regulation of homotypic vacuolar fusions. ScYcf1p plays a 
role in recruitment of the Soluble N-ethylmaleimide-sensitive factor Attachment protein 
REceptor (SNARE) vacuolar morphogenesis protein 7 (Vam7p) for stimulation of 
vacuole fusions [62]. The ATPase function of ScYcf1p was required for this fusion 
reaction to take place. 
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ScYcf1p also plays an important role in maintaining cellular balance under high-salt 
stress via its glutathione recycling function. If the expression of ScYCF1 is impeded, 
superoxide dismutase proteins (Sod1, Sod2) will compensate and maintain resistance to 
salt stress [63]. 
A recent study has shown that the copper chaperone for superoxide dismutase 1 (Ccs1) 
protein may be involved in ScYcf1p-mediating cadmium resistance because CCS1 
deletion blocks maturation of Sod1 and leads to oxidative inactivation of ScYcf1p [64]. 
Thus, copper metabolism, antioxidant enzymes, and cadmium defense appear to be 
intertwined. 
In contrast to the accumulating information about the functional roles of ScYcf1p in 
S. cerevisiae, little known about the putative orthologue CaYcf1p in C. albicans. 
 
Mlt1 Protein 
Multidrug resistant protein-like transporter (Mlt1) is an ABC transporter in C. albicans 
which is localized in the vacuolar membrane. It was first isolated in 2002 and MLT1 gene 
deletion mutants helped to reveal the protein’s involvement in virulence of C. albicans.[6]  
Like ScYcf1p, Mlt1p belongs to ABCC subfamily of ABC proteins. The structure of 
Mlt1p with the usual two TMDs and NBDs of the full-length ABCC transporters, is 
similar to ScYcf1p, also including the additional N-terminal extension domain with five 
trans-membrane helices, but substantial differences in the protein sequences [6, 7].  
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The gene designation MLT1 was given because of the structural similarities of the 
encoded protein with the human multidrug resistance-associated protein Mrp1; however, 
overall the protein sequence is more similar to ScYcf1 than Mrp1 [6]. Consequently, 
Mlt1p has been misnamed by some researchers as the C. albicans orthologue of ScYcf1p. 
However, the existence of a CaYCF1 gene and emerging evidence of distinctive 
functions of Mlt1p do support the notion that Mlt1p is not orthologous to ScYcf1p. For 
example, Mlt1p has been proven to be involved in endocytosis, oxidoreductase activities 
in cells, biofilm formation, hyphae formation, and virulence of C. albicans [7]. Mlt1p-
defective mutants failed to invade liver parenchyma of mice during peritoneal infection 
[6]. With the deletion of both MLT1 alleles in C. albicans, mutant cells are more 
susceptible to H2O2 and associated reactive oxygen species (ROS) [7]. However, ROS 
will also increase the expression level of glutathione in cells, which could overlap with 
the major function of ScYcf1p as glutathione-conjugation complex transporter [57].  
Thus, there is high possibility that Mlt1p is functionally closely related to ScYcf1p or its 
putative homologue CaYcf1p in C. albicans, not only because of highly similar protein 
structures, but also because of the involvement of both transporters in the response to 
oxidative stress. Investigation of functional overlaps between Mlt1p and CaYcf1p was 
one of the goals in this research project. 
 
Antifungal Drug Resistance 
Antifungal drug resistance is based on several major modes of resistance. One is natural 
or acquired resistance associated with reduced binding of a drug to its target due to 
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binding site modifications. Increased expression of the drug target could also lead to 
resistance development. Additionally, the action of efflux pumps which expel drugs from 
the intracellular environment and thus reduce or preclude contact with the drug target. 
Clinical resistance in combination with impaired immune functions or other co-infecting 
pathogens can render some fungal infections incurable by standard therapeutic 
approaches [65]. While fluconazole has been an effective treatment for several forms of 
candidiasis, resistance of C. albicans strains to this azole drug has increased substantially 
in recent years [66, 67]. 
Azoles are the most widely used antifungal drugs since 1958 [68]. The first azole 
antifungal drug was ketoconazole for systemic infections and later it was replaced 
fluconazole and itraconazole [69]. The antifungal mechanism of azoles is inhibition of 
the cytochrome P450 enzyme lanosterol 14α-demethylase which is a key enzyme in the 
biosynthesis of ergosterol, a crucial component of the fungal plasma membrane [70]. 
Blockage of ergosterol synthesis by azole interferes with fungal growth, but does not 
necessarily lead to cell death, i.e. the drugs are only fungistatic. 
Efflux pumps conferring resistance to azoles are located in the plasma membrane. The 
Candida drug resistance 1 and 2 (Cdr1, Cdr2) proteins are transporters belonging to 
ABCG or Pleiotropic Drug Resistance-like subfamily of the ABC protein superfamily [71] 
– they are the major efflux pumps reducing the intracellular drug concentration [72]. 
Cdr2p appears to exert supportive functions for Cdr1p. CDR2 expression alone is 
inefficient to reduce drug concentrations, while exclusive CDR1 expression is sufficient. 
In contrast to the Cdr proteins, the multidrug resistance protein 1 (Mdr1) is a member of 
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the major facilitator superfamily of transporters and seems restricted to the efflux of 
fluconazole [73]. 
The initial goal of this project was to determine the location of CaYcf1p in Candida 
albicans. I used green fluorescent protein fusion (GFP) protein constructs to indicate the 
potential location for CaYcf1p and compare it to previously published Mlt1p localization 
results [6]. For functional characterization, the susceptibilities of CaYCF1 mutants to 
cadmium and mercuric chloride and antifungals were tested in comparative analyses with 
MLT1 mutants. Real-time reverse transcriptase PCR was utilized for CaYCF1 and MLT1 







Fungal Strains and Culture Conditions 
C. albicans strains were routinely grown in YPD (yeast extract 10g/l, Peptone 20g/l, 
Dextrose 20g/l). Frozen stocks were kept at -80°C in YPD plus 20% glycerol as 
cryopreservative. Additional media such as synthetic defined medium (SD; yeast nitrogen 
base + complete Supplement Mixture (CSM) + 20% Glucose; Sunrise Science Products, 
San Diego, CA) and the cell culture media FluoroBrite DMEM (Dulbecco’s Modified 
Eagle Medium; Gibco, Thermo Fisher Scientific) and RPMI 1640 (with glutamine, 
without bicarbonate; Gibco, Thermo Fisher Scientific) were used as indicated in the 
following sections. Table 1 shows the C. albicans wild-type and mutant strains used in 
this study. Individual strain descriptions are summarized here: 
C. albicans SC5314 (CA200) is the wild-type parent strain used as control. 
C4GFP (CA201) and 6478GFP-1 (CA306) are mutant strains expressing C-terminal 
fusion proteins of GFP with Mlt1p and Ycf1p, respectively. These are Ura+ strains 
derived from the ura- strain C. albicans CAI4 [74]. 
Strain ST13-63 (CA239) is a complete MLT1 knock-out mutant with two disrupted 
alleles of the MLT1 gene. 
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Strain ST13-K1 (CA241) is a MLT1-complemented mutant derived from strain ST13-63 
which contains one functional MLT1 allele. 
Strain 353M1F34 (CA398) is a complete YCF1 knock-out mutant with two disrupted 
alleles of the YCF1 gene. 
Strain 398YCFF1 (CA437) is an YCF1 complemented mutant derived from strain 
353M1F34 which contains one functional YCF1 allele. 
Strain S49F6 (CA394) is a MLT1 and YCF1 double knock-out mutant with both alleles of 
the MLT1 and YCF1 genes disrupted. 
Strain S49F6R3FF35 (CA396) is an YCF1-complemented mutant derived from strain 
S49F6 with one intact allele of YCF1. 
Strain CAG31 (CA202) is a mutant strain expressing cytosolic GFP under the control of 
the constitutive β-Actin (ACT1) gene promoter. 
 
Growing Candida albicans mutants from stocks 
All wild-type and mutant C. albicans strains were inoculated on YPD agar plates from -
80°C stocks and grown for two days at 30°C. Single colonies were used to inoculate 
liquid cultures in YPD broth or other media. Depending on the experimental conditions, 
liquid cultures were incubated at 25°C, 30°C or 37°C with or without shaking at 180rpm 




Table 1. C. albicans wild-type and mutant strains used in this study 
 
 





wild-type strain CA200 [75] 
C4GFP CAI4 MLT1/MLT1-GFP-URA3 CA201 [6] 
6478GFP-1 CAI4 YCF1/YCF1-GFP-URA3 CA306 Koehler, G., 
unpublished 
ST13-63 ST13-12 mlt1-1Δ::hisG/mlt1-2Δ::hisG CA239 (mlt1/mlt1) [6] 
ST13-K1 ST13-63 MLT1-MPAR /mlt1-2Δ::hisG CA241 (MLT1/mlt1) [6] 
353M1F34 353MI ycf1Δ::FRT/ycf1Δ::FRT CA398 (ycf1/ycf1) Koehler, G., 
unpublished 
















CAG31 CAI4 ACT1/PACT1-GFP-URA3 CA202 [76] 
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Confocal Microscopy of GFP-labeled Candida albicans Mutants 
The C. albicans expressing GFP fusion proteins of Mlt1 or Ycf1 were used for protein 
localization experiments. The cytosolic GFP expressing strain CAG31 was used as a 
control. In addition to GFP fluorescence, strains were stained with additional dye for 
visualization of cellular structures such as the fungal cell wall or nuclei. 
 
Hoechst 33342 staining 
Hoechst 33342 (bisBenzimide H 33342 trihydrochloride; Millipore Sigma, Cat. No. 
14533, St Louis, MO) was used as nuclear counterstain (with incubation up to 60 
minutes). Stocks were prepared at 10mg/ml and stored at -20°C. 
 
Calcofluor White staining 
Calcofluor White (aka Fluorescent Brightener 28; MP Biomedicals, Santa Ana, CA), can 
be used to visualize the fungal cell walls. The stain was used at a final concentration of 
10µg/ml and staining for 30 – 60 minutes. Calcofluor White staining can be visualized by 
405nm excitation and DAPI emission settings. 
 
Confocal Microscopy 
C. albicans strains expressing GFP were grown in liquid YPD cultures and then used to 
inoculate 300 μl Gibco FluoroBrite DMEM medium (DMEM without phenol red) or SD 
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medium in eight-chamber culture slides. To determine whether the different forms of C. 
albicans would affect the location of Ycf1p, we incubated these cells under 30°C, 37°C 
and 37°C and 5% CO2 in a cell culture incubator for two to five hours. Subsequently, 
cells were stained with Hoechst 33342 by removing the medium and replacing it with 
fresh medium containing the Hoechst 33342 dye diluted to 0.1mg/ml and incubating the 
slides for 15 to 60 minutes to achieve staining of nuclei. Concomitantly, in several 
experiments cells additionally were stained with Calcofluor White as described above. 
Before observing under the confocal microscope, media in all chambers were removed 
and cells were washed with fresh media. After removal of the final wash, 200 μl of a 0.7% 
agarose solution in the respective medium were added to cover and immobilize cells in 
the chambers. Hoechst 33342 and/or Calcofluor White staining was detected using a 
Leica SPE confocal laser scanning microscope (Leica Microsystems Inc., Buffalo Grove, 
Il) with a 405nm laser for excitation and DAPI emission settings. GFP fluorescence was 
detected using excitation with 488nm laser and Leica emission settings for enhanced GFP 
(emission maximum at 510nm).  
 
Spot Assay of Candida albicans ABC Transporter Mutants 
100 µg/ml cadmium chloride YPD agar plates (60 ml in 150 x 15 mm petri dishes) were 
prepared for the spot assay. For inoculation, overnight cultures in YPD at 30°C of the 
wild-type strain CA200 and the ABC transporter mutant strains CA239, CA241, CA394, 
CA396, CA398, and CA437 (see Table 1) were prepared. The inocula were adjusted to 
equal optical densities of OD600nm = 1.0 in YPD broth. Subsequently, a dilution series was 
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prepared for each strain from the starting OD600nm = 1.0 by 1:5, 1:25, 1:125, 1:625, and 
1:3125 dilutions. For each strain, 2 μl of each dilution were spotted in a row on the 
cadmium chloride YPD plates. The spot assays were prepared for incubation at 30°C and 
37°C. Plates were photographed after 4 days of incubation at the respective temperature. 
Overall, experiments were performed in triplicates. 
 
Disk Diffusion Assays with Cadmium, Mercury, and Lead Compounds 
The CA200 wild-type and the CA239, CA241, CA394, CA396, CA398, CA437 mutants 
were grown overnight in YPD broth. The OD600nm of each culture was measured and each 
strain was diluted to an OD600nm of 0.01 in 25 ml liquid YPD soft agar with 0.7% w/v 
agarose which was kept at 45°C to avoid premature solidification. The inoculated soft 
agars were poured immediately on top of solidified 60 ml YPD agar in 150 x 15 mm petri 
dishes and allowed to solidify at room temperature. For each tested compound, five paper 
disks were carefully loaded with 15 µl of 50 mg/ml, 5 mg/ml, 500 µg/ml, 50 µg/ml and 
5 µg/ml of either mercuric chloride, cadmium chloride, or lead-acetate solution. Each set 
of disks was deposited on the solidified YPD soft agar overlay plates. The plates were 
incubated at 30°C for 2 days and subsequently photographed to document growth 




Broth Microdilution Assays for CdCl2 and HgCl2 in ABC Transporter Mutants 
Various media were tested for the broth microdilution assays with cadmium and mercury 
salts. Following these pilot experiments, the media of choice for the assays were SD 
medium and RPMI 1640 buffered to pH 7.0 with 0.165 M morpholinepropanesulfonic 
acid (MOPS) and 2% glucose (RPMI-1640-MOPS-2%Glc), a medium adapted from 
NCCLS recommendations for C. albicans antifungal drug susceptibility testing [77]. 
For the microdilution assay, the CA200 wild-type strain and the ABC transporter mutant 
strains CA398, CA437, CA394, CA396, CA398, and CA437 were grown overnight in 
SD medium. The optical densities of the cultures were measured and the strains were 
diluted to an OD600nm = 0.1 in SD medium. One hundred µl of 400 µg/ml, 200 µg/ml, 
100 µg/ml, 50 µg/ml, 25 µg/ml, 12.5 µg/ml, 6.25 µg/ml cadmium chloride or mercuric 
chloride solution in the same medium were added into 96-well flat-bottom microplates. 
Control wells with no addition of cadmium or mercury salts were included. Subsequently, 
100 µl of the strain dilutions were added to each control well and the wells containing the 
toxic metal salt dilutions. This procedure resulted in final cadmium or mercuric chloride 
concentrations of 200, 100, 50, 25, 12.5, 6.25, 3.125, and 0 µg/ml and an OD600nm of 0.05 
for each strain. The microplates were incubated at 37°C without shaking. After 24 and 48 
hours of incubation, plates were shaken on a microplate shaker for 5 mins at 800rpm and 
subsequently the optical densities at 600nm were measured in a Biotek Synergy 2 Multi-





Broth Microdilution Assay for Fluconazole in ABC Transporter Mutants 
The susceptibility of C. albicans wild-type and control strains to fluconazole was tested 
using a broth microdilution assay similar to the assay described in the previous section, 
following NCCLS guidelines [77]. Briefly, fluconazole dilution series were prepared 
from an aqueous 12,800 mg/L fluconazole stock solution to achieve final concentrations 
of 64, 32, 16, 8, 4, 2, 1, 0.5, 0.25, and 0.125 mg/L in 96-well microplates. The growth 
medium of choice was RPMI-1640-MOPS-2%Glc (see above). Wells were inoculated 
with C. albicans strains grown in overnight cultures and adjusted to OD600nm of 0.1 – 
following use of 100 μl cell suspension and 100 μl 2x drug solution the final starting 
OD600nm was 0.05. Control wells included wells with no drug and wells with no 
inoculation of C. albicans cells as blanks. The assay microplates were incubated at 37°C 
without shaking. After 24 and 48 hours of incubation, plates were shaken on a microplate 
shaker for 5 mins at 800rpm and subsequently OD600nm values were measured in a Biotek 
Synergy 2 Multi-mode plate reader. Experiments were repeated twice in duplicates. 
 
RT-qPCR of CaYCF1 and MLT1 mRNA Expression in Presence of HgCl2 
C. albicans cultures for RNA extraction 
The wild-type C. albicans strain CA200 (genotype MLT1/MLT1 YCF1/YCF1), the 
complete MLT1 gene disruption mutant CA239 (mlt1/mlt1) and its complemented 
derivative CA241 (mlt1/MLT1) as well as the YCF1 gene disruption mutant CA398 
(ycf1/ycf1) and the YCF1-complemented strain CA437 (ycf1/YCF1) were used for MLT1 
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and YCF1 mRNA expression analyses by reverse transcriptase quantitative PCR (RT-
qPCR). 
The strains were cultured overnight in SD medium at 30°C in a shaking incubator. The 
next morning, the optical densities of each culture were determined and the strains were 
diluted in fresh medium to an OD600nm of 0.1. The resulting cultures were incubated in 6-
well tissue culture plates (3 ml per well) at 30°C with 115 rpm rotatory shaking. After 
3 hours of growth, 0.9 µl 50 mg/ml HgCl2 solution was added to the wells 15 µg/ml as 
the final HgCl2 concentration. The control wells for each strain did not receive HgCl2. 
Subsequently, plates were incubated under the same conditions for another 2 hours. For 
total RNA isolation, cultures were transferred to 15 ml tubes and cells were harvested by 
centrifugation (10 mins at 4,500 × g, 4°C) and immediately frozen at -80°C until RNA 
extraction.  
RNA extraction and quality control 
Total RNA was isolated using the ZR Quick-RNA™ MiniPrep Plus kit (Zymo Research, 
Irvine, CA) according to the manufacturer’s instructions. Briefly, the harvested Candida 
cells were directly homogenized using bead bashing tubes (Zymo Research) with 1X 
DNA/RNA Shield™ and 200 µl nuclease free water in a Mini-Beadbeater -96 (Biospec 
Products, Bartlesville, OK) with beating for two times 1 min. Subsequently, tubes were 
centrifuged for 1 min at 15,000 × g. and the supernatant was transferred to new nuclease-
free tubes for RNA isolation. Depending on the amount of supernatant, an equal volume 
of RNA Lysis Buffer was added to each tube to complete lysis.  To remove the majority 
of genomic DNA, the samples lysed in RNA Lysis Buffer were transferred into Spin-
Away™-Filter and centrifuged at 15,000 g for 1 minute. Subsequently, equal volumes of 
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ethanol (100%) were added to the sample flow-through. Samples were well mixed by 
gentle pipetting up and down and transferred into a Zymo-Spin IIICG™ Column. The 
columns were centrifuged at 15,000 × g for 30 seconds. Following centrifugation, the 
flow through was discarded and RNA samples were immediately subjected to in-column 
DNAse I treatment following the manufacturer’s protocols. For this treatment, 400 µl 
RNA Wash Buffer were added to each Spin IIICG™ column and centrifuged at 
15,000 × g for 30 seconds. After the washing step, the columns were placed in new 
collection tubes and a DNase I solution mixture of 5 µl (1U/µl DNase I and 75 µl DNA 
digestion buffer) was directly added to each column matrix and incubated for 15 min at 
25°C. Following DNase I treatment, 400 µl RNA Prep Buffer was added to each column 
and these were centrifuged at 15,000 × g for 1 minute. For washing the RNA bound to 
the columns, 700 µl of RNA Wash Buffer were added to the columns, followed by and 
centrifugation at 15,000 × g for 30 seconds. The washing step was repeated with 400 µl 
RNA wash buffer and centrifugation at 15,000 × g for 2 minutes to ensure the complete 
removal of wash buffer. Finally, each column was placed in a sterile nuclease-free 
Eppendorf tube and 100 µl DNase/RNase free water were added. The RNAs were eluted 
by centrifugation at 10,000 × g for 30 seconds. The eluted total RNAs were stored at -
80°C. 
RNA concentrations were determined by 260 nm and 280 nm readings using a Take 3 
Micro –volume plate in a BioTek Synergy 2 Multi-mode plate reader. The integrity of the 
extracted RNAs was verified by agarose gel electrophoresis (1% agarose; TAE buffer). 
Following gel electrophoresis, gels were stained with SybrSafe (Thermo Fisher Scientific) 
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and imaged on a Typhoon 9410 Variable Mode imager. Clearly, defined 16S and 23S 
ribosomal RNA bands were indicative of good quality RNAs. 
Reverse Transcription and quantitative PCR 
Reverse transcription to generate cDNA was performed using Applied Biosystems High 
Capacity RNA-to-cDNA kit following manufacturer’s instructions (Applied Biosystems 
Foster City, CA). Briefly, 10 µl of 2x RT Buffer, 1 µl of 20x RT enzyme, and up to 9 µl 
of total RNA sample (2 µg maximum capacity per 20 µl reaction) were pipetted into a 0.5 
ml PCR tube. Nuclease-free water was added to reach a final volume of 20 µl. The 
Eppendorf tubes were placed on a BIO-RAD DNA Engine PT200 thermal cycler and 
incubated for 60 min at 37°C followed by 5 min at 95°C to stop the reaction and cooling 
to 4°C. The cDNA reaction tubes for each sample were stored at -20°C for future use. 
Quantitative PCR reaction mixtures were prepared using PowerUP™ SYBR Green 
Master Mix (Applied Biosystems Foster City, CA). Each reaction was run in duplicate in 
a final volume of 10µl containing 5 µl PowerUp SYBR Green Master Mix (2X), 0.2 µl 
each of the gene-specific forward and reverse primers, 1 µl of cDNA template, and 3.6 µl 
of nuclease-free water. Primer sequences for the MLT1 and CaYCF1 genes as well the C. 
albicans Actin 1 (ACT1) housekeeping gene are shown in Table 2. Reaction were set up 
in 96-well PCR semi-skirted reaction plates and sealed with ThermalSeal adhesive film 
(Phenix Research Products, Candler, NC). 
The PCR reaction plates were centrifuged at 4000 g for 5 minutes at 4°C.  Quantitative 
PCR reactions were run on an Applied Biosystems 7500 Real-time PCR system with the 
following reaction parameters: 2 min at 50°C, 2 min at 95°C, 40 cycles of denaturation 
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for 15 seconds at 95°C and annealing/extension for 1 min at 60°C. Relative quantitation 
qPCR data were analyzed using the ΔΔCq method.  






















Functional characterization of the C. albicans ABC transporter CaYcf1 in this study 
encompassed detection of the putative cellular location of the transporter and toxic metal 
susceptibility assays with specific gene disruption mutants to define some of the transport 
functions of this protein. All experiments included comparative analyses with the related 
Mlt1 transporter. Furthermore, gene expression analyses were performed in the presence 
of mercuric chloride to assess whether the CaYCF1 gene is induced under these 
conditions and whether any compensatory gene regulation takes place in CaYCF1 and 
MLT1 gene disruption mutants. 
 
Cellular Localization of the CaYcf1 ABC transporter 
Confocal microcopy was used to detect where the YCF1::GFP and MLT1::GFP fusion 
proteins localize in C. albicans cells. For comparison, strain CAG31 was used to 
demonstrate cytosolic expression of GFP. The following section shows representative 
images illustrating that the C-terminal GFP fusion proteins of both ABC transporters 
localize to the vacuolar membrane. 
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Figure 1 depicts images of the MLT1-GFP fusion protein in yeast and pseudohyphal cells 
of C. albicans C4GFP. The fusion protein clearly localizes to the membranes of large and 
multiple smaller vacuoles.  
 
Fig. 1. Confocal imaging of strain C4GFP expressing the MLT1::GFP fusion protein 
Calcofluor White (CW) cell wall staining and GFP fluorescence (GFP) confocal images 
as well as differential interference contrast imaging (DIC) using transmitted light 
detection are shown. The right panel (Merged) represents an overlay of the images to the 
left. The ABC transporter GFP fusion protein does not localize to the plasma membrane, 
but to the vacuolar membrane. Cells with vacuoles in different sizes and configurations 
are shown. 
 
In Figure 2 C4GFP budding yeast cells and pseudohyphae are shown with GFP 
fluorescence in multiple vacuoles of different sizes and numbers per cell. 






Fig. 2. Overlay image of strain C4GFP expressing the MLT1::GFP fusion protein 
Confocal images of CW and GFP fluorescence were merged with the DIC image. The 
localization of GFP fluorescence clearly can be seen in the membranes of multiple small 
vacuoles in most cells that have not fused into a large vacuole. Some cells in the DIC 





In contrast to the distinct localization of the Mlt1-GFP ABC transporter fusion protein in 
vacuolar membranes, the cytosolic GFP expressed by the constitutive ACT1 promoter in 
strain CAG31 can be seen throughout most of the intracellular space (see Figure 3). 
 
Fig. 3. Expression of cytosolic GFP in strain CAG31 
For comparison with the ABC transporter fusion proteins, the images show a 
pseudohypha expression cytosolic GFP under control of the constitutive ACT1 promoter. 
GFP fluorescence can be seen throughout the cytoplasm with the exception of areas 
occupied by vacuoles or nuclei. 
 
In strain 6478GFP-1, the introduced C. albicans YCF1::GFP gene leads to expression of 
a fusion protein that, similar to the Mlt1-GFP protein, appears to localize to the vacuolar 
membrane (see Figure 4). Overall, the expression of this protein seems weaker than the 





Fig. 4. Confocal imaging of strain 6478GFP expressing the YCF1::GFP fusion 
protein 
GFP fluorescence (GFP) and Calcofluor White (CW) as well as the overlay of both 
(Merged) are shown. Similar to Mlt1-GFP, the ABC transporter GFP fusion protein does 
not localize to the plasma membrane, but to the vacuolar membrane. A pseudohypha with 
multiple smaller vacuoles is shown. Note the thin tubular connections between larger 
vacuoles in the germ tube. 
 
 
C. albicans 6478GFP-1 germ tubes, precursors of true hyphae, also show green 
fluorescence in vacuolar membranes, indicating that this morphological form also 





Fig. 5. Confocal imaging of the Ycf1-GFP protein in C. albicans germ tubes. 
The green, ring-like fluorescence visible in the GFP and merged image indicates multiple 








Fig. 6. Confocal imaging of the Ycf1-GFP protein in a single C. albicans germ tube 
and mother cell. 
GFP fluorescence, DIC, and merged images are shown from a single Z-stack slice (A) 
and a maximum projection of 30 Z-stack slices. In the DIC image, a long vacuole can be 
seen in the germ tube which appears to accumulate the GFP fusion protein (see GFP 
image in A). The maximum projection GFP image in (B) reveals an agglomerate of 
smaller vacuoles in the mother cell. 
 
Figure 7 shows another example of Mlt1-GFP fluorescence in budding yeast cells, within 







Fig. 7. Single slice and maximum projection of a confocal microscopy Z-stack of 
yeast cells expressing Mlt1-GFP.  
A single Z-stack section (A) and a maximum Z-stack projection (B) is shown from 
budding yeast cells of C4GFP. Ring-like green fluorescence in these images indicates the 
vacuolar membrane localization of the Mlt1-GFP fusion protein. The DIC image in (A) 
also reveals the large vacuole in the mother cell. The Calcofluor White (CW) blue 









Spot Assay of Candida albicans ABC Transporter Mutants 
Plate spot assays are a qualitative method to detect increased susceptibilities of gene 
disruption mutants towards toxic chemicals included in the agar medium. The following 
shows the results of a spot assay with the C. albicans ABC transporter mutants and 
controls on agar plates containing CdCl2. 
 
 
Fig 8. Spot assay with ABC transporter mutants. 
Serial dilutions of strains of CA200, CA239, CA241, CA394, CA396, CA398 and 
CA437 were spotted on agar plates with 100 μg/ml cadmium chloride and incubated at 
30°C (A) and 37°C (B) for 4 days. The ycf1/ycf1 mutant CA394 and the ycf1/ycf1 
mlt1/mlt1 double gene disruption mutant CA398 are hypersensitive to CdCl2, while the 
mlt1/mlt1 single knock-out strain CA239 does not show this phenotype. Strains CA396 












At 30°C and 37°C the ycf1/ycf1 mutants were highly susceptible to CdCl2. The wild type 
and mlt1/mlt1 mutants showed similar resistance to the compound and grew even at the 
highest dilution of the inoculum. The heterozygous YCF1 complemented strains showed 
intermediate susceptibility. Thus, Ycf1p appears to be involved in cadmium resistance. 
 
 
Agar Disk Diffusion Assays with Cadmium, Mercury, and Lead Compounds 
Disk diffusion assay were carried out with CdCl2, HgCl2, and Pb(CH3OO)2 in order to 
semi-quantitatively determine the susceptibility of wild-type and ABC transporter 
mutants to these compounds.  
Representative results of cadmium chloride disk diffusion assays are shown in Figure 9 




Fig. 9. CdCl2 disk diffusion assay. Strains CA200, CA239, CA241, CA394, CA396, 
CA398, CA437 were inoculated at OD600= 0.01 in a 0.7% soft agar overlay. Disk loaded 
with 10 µl of 50mg/ml, 5mg/ml, 500 μg/ml, 50 μg/ml, 5 μg/ml of cadmium chloride 








Table 3. Diameters of inhibition zones in CdCl2 disk diffusion assays after 24 hours. 
CdCl2 concentration used 
Strain 50 mg/ml 5 mg/ml 500 μg/ml 50 μg/ml 5 μg/ml 
CA200 1.9 cm 1.3 cm - - - 
CA239 2.3 cm 1.6 cm - - - 
CA241 2.2 cm 1.4 cm 0.9 cm - - 
CA394 2.4 cm 1.8 cm 1.0 cm 0.7 cm - 
CA396 2.3 cm 1.4 cm 0.9 cm 0.7 cm - 
CA398 2.8 cm 1.9 cm - - - 
CA437 2.4 cm 1.7 cm 0.8 cm - - 
 
The results of the disk diffusion assay suggest that CaYcf1 and to lesser extent Mlt1 are 
involved in cadmium chloride resistance. 
 
Representative results of mercuric chloride disk diffusion assays are shown in Figure 10 








Fig. 10. HgCl2 disk diffusion assay. Strains CA200, CA239, CA241, CA394, CA396, 
CA398, CA437 were inoculated at OD600= 0.01 in a 0.7% soft agar overlay. Disk loaded 
with 10 µl of 50mg/ml, 5mg/ml, 500 μg/ml, 50 μg/ml, 5 μg/ml of mercuric chloride 








Table 4. Diameters of inhibition zones in HgCl2 disk diffusion assays after 24 hours 
HgCl2 concentration used 
Strain 50 mg/ml 5 mg/ml 500 μg/ml 50 μg/ml 5 μg/ml 
CA200 1.8 cm 1.1 cm 0.9 cm - - 
CA239 1.9 cm 1.1 cm 0.9 cm - - 
CA241 1.7 cm 1.2 cm 0.9 cm 0.8 cm 0.7 cm 
CA394 3.0 cm 1.9 cm 1.3 cm - - 
CA396 1.9 cm 1.2 cm 0.8 cm 0.7 cm - 
CA398 2.1 cm 1.2 cm 0.9 cm 0.7 cm - 
CA437 1.8 cm 1.1 cm 0.8 cm - - 
 
The results of the HgCl2 disk diffusion assay suggest that Ycf1 is involved in cadmium 
resistance. Interestingly, the double mutant ycf1/ycf1 mlt1/mlt1 CA398 appeared to be 
less susceptible to mercuric chloride than the single ycf1/ycf1 mutant CA394. 
 
Pb(CH3OO)2 disk diffusion assay with strains CA200, CA239, CA241, CA394, CA396, 
CA398, CA437 were conducted in similar manner as the aforementioned assays. 
However, disks loaded with 10 µl of 50 mg/ml, 5 mg/ml, 500 μg/ml, 50 μg/ml, 5 μg/ml 
of lead (II) acetate solution did not yield inhibition zones with the wild-type or mutant 
strains. Thus this compound appeared to have no effect on Candida growth or it did not 
diffuse into the medium. 
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Broth Microdilution Assays with CdCl2, HgCl2  
Broth microdilution assays were used to assess the susceptibility of the ABC transporter 
mutants to CdCl2 and HgCl2 in SD medium.  
Figure 11 shows the results of the microdilution assay using CdCl2 as growth inhibitor 
and Figure 12 shows the broth microdilution results with HgCl2. 
 
Fig. 11. Growth inhibition of the C. albicans strains in CdCl2 microdilution assays. 
Growth of the homozygous and heterozygous ycf1 mutants CA394, CA396, CA398 and 
CA437 mutants is decreased at 100 μg/ml of CdCl2, (but not significant by ANOVA). 


































CA200(wild type) CA239(mlt1/mlt1) CA241(mlt1/MLT1) CA394(ycf1/ycf1 mlt1/mlt1)




Fig. 12. Growth inhibition of the C. albicans strains in HgCl2 microdilution assays. 
Growth of homozygous ycf1/ycf1 mutants CA394 and CA398 mutants is substantially 
decreased already at 6.25 μg/ml of HgCl2 (ANOVA, p<0.05). Heterozygous ycf1/YCF1 
mutants and MLT1 mutants reveal growth reduction at 12.5 μg/ml of HgCl2, which may 
indicate that losing one allele of YCF1 or MLT1 could increase susceptibility to HgCl2. 
The results after 24 h of incubation are shown. 
 
Broth Microdilution Assay with Fluconazole 
In order to assess whether C. albicans ycf1 and/or mlt1 mutations increase susceptibility 
to the antifungal drug fluconazole, broth microdilution assays were conducted similar to 

































CA200(wild type) CA239(mlt1/mlt1) CA241(mlt1/MLT1) CA394(ycf1/ycf1 mlt1/mlt1)






Fig. 13. Growth inhibition of the C. albicans strains in fluconazole microdilution 
assays. Results indicate no significant differences in fluconazole resistance (up to 
64 µg/ml) between wild-type and the vacuolar ABC transporter mutants. Results after 
48h incubation are shown. 
 
RT-qPCR of CaYCF1 and MLT1 mRNA Expression in Presence of HgCl2 
A reverse transcriptase qPCR analysis was conducted to investigate how MLT1 and YCF1 
mRNA expression in wild-type and mutant C. albicans strains is affected by the presence 
of mercuric chloride. Figures 14 and 15 show representative results of these experiments. 
MLT1 expression is generally reduced during presence of the salt, especially in cells 





Fig. 14. MLT1 mRNA expression in C. albicans strains during HgCl2 exposure.  
Results of the RT-qPCR with the wild-type strain CA200, the mlt1/MLT1 mutant CA241, 
the homozygous ycf1 mutant CA398, and the YCF1-complemented strain with and 
without exposure to HgCL2 are shown. CA200 MLT1 expression without HgCL2 
exposure was used as the calibrator. The expression of MLT1 appears to be reduced by 
the presence of HgCL2, especially in the wild-type and the complete ycf1 knock-out. 



























Fig. 15. YCF1 mRNA expression in C. albicans strains during HgCl2 exposure. 
Results of the RT-qPCR with CA200, the mlt1/mlt1 mutant CA239, the homozygous mlt1 
mutant CA239, the MLT1 (CA241) and the YCF1 complemented strain CA437 with and 
without exposure to HgCl2 are shown, CA200 YCF1 expression without HgCL2 exposure 
was used as the calibrator. Exposure to the salt increases expression of YCF1, with the 

























YCF1 allele. Nevertheless, expression of the remaining intact allele appears to be 
increased during mercury exposure.  
 
In summary, the results of this study showed that the ABC transporter encoded by the 
C. albicans gene CaYCF1 does confer resistance to cadmium and mercury ions. 
Consequently, CaYCF1 also is induced by presence of mercuric chloride. The related 
ABC transporter Mlt1p does not show major involvement in cadmium and mercury 
resistance, nor does it appear to be directly induced by mercuric chloride. Furthermore, 
evidence was provided that, like Mlt1p, the CaYCF1-encoded ABC transporter localizes 








There are at least 18 ABC transporters encoded in the Candida albicans genome, but 
only a few of them have been well characterized [53]. Our study was focused on two 
C. albicans ABC transporters, CaYcf1p and Mlt1p. The CaYcf1p orthologue ScYcf1p 
was first discovered in Saccharomyces cerevisiae and has been studied in detail in this 
yeast [57]. However, S. cerevisiae as a non-pathogenic fungus could not instruct us on 
the potential role of this ABC transporter in virulence. Furthermore, as a vacuolar 
membrane transporter, most of Ycf1p’s function should be related to the role of vacuoles 
in fungal cell biology. Vacuoles are important organelles that have crucial intracellular 
functions such as sequestration of toxic chemicals as glutathione-conjugated complexes 
and involvement in reproduction via budding in yeasts or in filamentous growth which is 
a characteristic processes in molds and some yeast-like fungi [39, 78]. Thus, this study’s 
goal was to initiate the functional characterization of CaYcf1p in the pathogenic yeast 
C. albicans which is, in contrast to S. cerevisiae, capable of growing in various 
filamentous forms, i.e. pseudohyphae and true hyphae.  
The vacuolar ABC transporter Mlt1p on the other hand was characterized first in 
C. albicans by Theiss and coworkers [6] – the existence of a true orthologue of this 
transporter in S. cerevisiae is unclear. C. albicans MLT1 gene deletion affected lipid
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homeostasis, endocytosis, oxidoreductase activities, and hyphal development [7]. The 
deletion mutants also revealed a virulence defect because they were unable to invade 
liver tissue during peritoneal infection of mice [6]. 
One goal of the current study was the determination of the cellular localization of the 
CaYcf1p transporter. The C-terminal GFP fusion proteins of CaYcf1p expressed by the 
strain C albicans 6748GFP as well as Mlt1p-GFP expressed by C4GFP were detected by 
light microscopy in vacuolar membranes; thus, confirming that both transporters likely 
are occupying similar intracellular sites. The vacuolar membrane localization of CaYcf1p 
also is consistent with the localization of the orthologous protein ScYcf1p in S. cerevisiae 
[56, 57].  The employment of C-terminal fusions instead of N-terminal fusion constructs, 
which are more likely to be defective in vacuolar targeting, appears to be a successful 
strategy to elucidate the localization of these ABC transporters in intracellular 
membranes. Interestingly, Mason and Michaelis have shown that the N-terminal 
extension domain of the MRP-like ScYcf1p is crucial for targeting to the vacuole [55]. 
The GFP-fusion protein strategy was successful in yeast, pseudohyphal, and hyphal 
forms of the fungi (see Figures 1 to 7). The predominance of smaller vacuoles in the 
Ycf1p-GFP mutant 6478GFP-1 could indicate that this mutant exhibits reduced tendency 
to form larger vacuoles. This could also be indicative for functional impairment of the 
GFP-labeled allele in combination with a putative involvement of CaYcf1p in vacuole 
fusion as it was reported for the S. cerevisiae orthologue ScYcf1 [38, 62]. Future studies, 
will take advantage of the complete CaYCF1 gene knock-out to investigate further the 
role of CaYcf1p in vacuole fusions in C. albicans.  
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Another interesting finding are the tracks of Ycf1p-GFP fluorescence between vacuoles 
(see pseudohypha in Figure 4). These tracks could represent tubular connections between 
individual vacuoles in growing cells that lead to propagation of vacuoles along the 
expanding filaments. Again, this could indicate that CaYcf1 is involved in vacuolar 
fusion and trafficking. Previous studies have demonstrated that vacuoles are required for 
cell-cycle progressing and daughter cells will receive organelles from their mother cells 
[79]. During the yeast cell budding process, the mother cell vacuole will start to extend 
portions into the emerging bud [78]. In the C. albicans Ycf1p-GFP fusion strain mother 
cells of germ tubes (Figure 6) are full of small vacuoles that might be trafficking into the 
expanding germ tube to form new, larger vacuoles. 
In addition to the localization experiments, several approaches to determine the role of 
CaYcf1p in detoxification of toxic metal ions such as cadmium, mercury and lead ions 
were used in this study. Gene disruption mutants of MLT1 and CaYCF1 and their 
associated complemented strains with single intact alleles were crucial in the comparison 
with wild-type susceptibility to these toxic chemicals. A spot assay using wild-type and 
mutant strains revealed clear hypersensitivity to CdCl2 in ycf1/ycf1 mutants (see Figure 8; 
CA394 and CA398) that was partially complemented by introduction of a single intact 
YCF1 allele in the complemented strains (CA437 and CA396). In this assay, no 
differences were detected after incubation at 30ºC and 37ºC. Because of the increased 
tendency of C. albicans for filamentous growth at elevated temperature, future 
experiments will explore whether there are disparate susceptibilities in the wild-type and 
mutant strains during growth in pure yeast, pseudohyphal and hyphal forms.  
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Most studies on the functions of Ycf1p focused on the yeast like S. cerevisiae [56, 61, 64] 
which does not form true hyphae; therefore, studies in pleomorphic and pathogenic 
fungus C. albicans could reveal novel insights into the role of Ycf1p in detoxification 
during exposure to environmental conditions that favor filamentous growth, including 
those conditions in the mammalian host. 
The results of this study, revealed no substantial association of the Mlt1 ABC transporter 
with cadmium and mercury detoxification. Further studies employing different media and 
growth conditions are needed to confirm this notion. CaYcf1p on the other hand appears 
to be clearly involved in the detoxification of the toxic compounds, confirming CaYcf1 
as the true orthologue of ScYcf1p which has been shown to exert these activities in 
S. cerevisiae according to lots of earlier studies.[56-58, 60]. The disk diffusion assays and 
broth microdilution assays performed in our study further confirm the role of CaYcf1p in 
resistance to toxic cadmium and mercury compounds (see Figures 9-12; Tables 3 and 4). 
The failure of lead (II) acetate to inhibit growth of C. albicans in the disk diffusion assay 
requires further investigation, possibly using different approaches or lead compounds. 
Potential reasons for this failure could be impaired agar diffusion or restricted access of 
lead (II) acetate to the intracellular environment [80]. The notoriety of lead as 
environmental toxin certainly warrants further study [81]. Lead is likely to be harmful to 
C. albicans because of its ability to bind sulfate groups and to interfere with the structural 
organization of zinc fingers in enzymes [82]. 
One of the most important functions of ABC transporters in the plasma membrane is drug 
efflux, on cause for antifungal drug resistance [71]. Multidrug resistance-associated 
protein 1 (Mrp1) in humans also belongs to ABCC subfamily. A previous study showed 
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that Mrp1 can complement an ycf1 defect in yeast and restore transport of glutathione 
conjugate complexes [61]. For this reason, we tried to test whether Ycf1p and Mlt1p are 
involved in resistance to fluconazole. However, we did not find convincing evidence that 
these ABC transporters play a role in fluconazole resistance (Figure 13) . Previous 
research showed that Mlt1p is involved antifungal drug resistance [7]. The wild-type 
strain used in this study appeared to exhibit high levels of fluconazole resistance; thus, 
any potential effect of the vacuolar transporters could be masked by the strong activities 
of plasma membrane efflux pumps [83, 84]. 
The RT-qPCR expression analyses in this study revealed that CaYCF1 expression levels 
increased when mercuric chloride was present, further confirming Ycf1p’s role in 
mercury detoxification (see Figures 14 and 15). Decrease of MLT1 expression during 
exposure to the salt could be caused by a general downregulation of gene expression due 
to the toxi effects of the compound – this was especially pronounced in ycf1 mutants that 
apparently lack a major mercury detoxification mechanism. How potential vacuolar 
fusion or trafficking defects in these mutants might affect detoxification remains to be 
elucidated. Our single and double ABC transporter disruption mutants could be valuable 
tools to explore details of the detoxification and gene regulation processes.  
In conclusion, the initial functional characterization of the C. albicans vacuolar 
membrane ABC transporter CaYcf1p in this study has confirmed that this protein is 
indeed the homologue of ScYcf1p in S. cerevisiae. However, the fact that this ABC 
transporter is situated in a pathogenic fungus with multiple morphologies, has opened 
new lines of investigation towards its role in filamentous growth, vacuole inheritance, 
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